Previous close | 61.50 |
Open | 61.50 |
Bid | 63.15 |
Ask | 64.75 |
Strike | 65.00 |
Expiry date | 2025-01-17 |
Day's range | 61.50 - 61.50 |
Contract range | N/A |
Volume | |
Open interest | 39 |
Moderna ( NASDAQ:MRNA ) First Quarter 2024 Results Key Financial Results Revenue: US$167.0m (down 91% from 1Q 2023...
Despite a significant revenue drop, Moderna showcases robust clinical progress and strategic collaborations.
The drugmaker is optimistic about higher sales with new vaccines and a little help from AI in the coming years.